{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:44:33Z","timestamp":1790239473618,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,6]]},"DOI":"10.7759\/cureus.63961","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T12:42:05Z","timestamp":1720269725000},"source":"Crossref","is-referenced-by-count":3,"title":["Pregnancy-Induced Hypertension Pathophysiology and Contemporary Management Strategies: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Garima S","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daksh","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dushyant","family":"Bawiskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saylee S","family":"Shedge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101853RR","article-title":"The genetic risk factors for pregnancy-induced hypertension: Evidence from genetic polymorphisms","volume":"36","author":"Wei W","year":"2022","unstructured":"Wei W, Wang X, Zhou Y, Shang X, Yu H. The genetic risk factors for pregnancy-induced hypertension: Evidence from genetic polymorphisms. FASEB J. 2022, 36:e22413. 10.1096\/fj.202101853RR","journal-title":"FASEB J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2016.105","article-title":"Starting the new review series:  pregnancy-induced hypertension","volume":"40","author":"Ishimitsu T","year":"2017","unstructured":"Ishimitsu T. Starting the new review series:  pregnancy-induced hypertension. Hypertens Res. 2017, 40:3-4. 10.1038\/hr.2016.105","journal-title":"Hypertens Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-102008","article-title":"Renin-angiotensin-aldosterone system in the pathogenesis of pregnancy-induced hypertension","volume":"126","author":"\u015awi\u0105tkowska-Stodulska R","year":"2018","unstructured":"\u015awi\u0105tkowska-Stodulska R, Kmie\u0107 P, Stefa\u0144ska K, Sworczak K. Renin-angiotensin-aldosterone system in the pathogenesis of pregnancy-induced hypertension. Exp Clin Endocrinol Diabetes. 2018, 126:362-6. 10.1055\/s-0044-102008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.33314\/jnhrc.v19i2.3589","article-title":"Prevalence, risk factors and outcome of pregnancy induced hypertension in Nepal: a meta-analysis of prevalence studies","volume":"19","author":"Shrestha DB","year":"2021","unstructured":"Shrestha DB, Budhathoki P, Malbul K, et al.. Prevalence, risk factors and outcome of pregnancy induced hypertension in Nepal: a meta-analysis of prevalence studies. J Nepal Health Res Counc. 2021, 19:221-9. 10.33314\/jnhrc.v19i2.3589","journal-title":"J Nepal Health Res Counc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2020.09.005","article-title":"Hypertensive disorders of pregnancy","volume":"39","author":"Khedagi AM","year":"2021","unstructured":"Khedagi AM, Bello NA. Hypertensive disorders of pregnancy. Cardiol Clin. 2021, 39:77-90. 10.1016\/j.ccl.2020.09.005","journal-title":"Cardiol Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association","volume":"79","author":"Garovic VD","year":"2022","unstructured":"Garovic VD, Dechend R, Easterling T, et al.. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association. Hypertension. 2022, 79:e21-41. 10.1161\/HYP.0000000000000208","journal-title":"Hypertension"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-022-00965-6","article-title":"Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement","volume":"45","author":"Metoki H","year":"2022","unstructured":"Metoki H, Iwama N, Hamada H, Satoh M, Murakami T, Ishikuro M, Obara T. Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement. Hypertens Res. 2022, 45:1298-309. 10.1038\/s41440-022-00965-6","journal-title":"Hypertens Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.s4009","article-title":"Pathophysiology of placentation abnormalities in pregnancy-induced hypertension","volume":"4","author":"Furuya M","year":"2008","unstructured":"Furuya M, Ishida J, Aoki I, Fukamizu A. Pathophysiology of placentation abnormalities in pregnancy-induced hypertension. Vasc Health Risk Manag. 2008, 4:1301-13. 10.2147\/vhrm.s4009","journal-title":"Vasc Health Risk Manag"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.14310\/horm.2002.1582","article-title":"Pregnancy-Induced hypertension","volume":"14","author":"Kintiraki E","year":"2015","unstructured":"Kintiraki E, Papakatsika S, Kotronis G, Goulis DG, Kotsis V. Pregnancy-Induced hypertension. Hormones (Athens). 2015, 14:211-23. 10.14310\/horm.2002.1582","journal-title":"Hormones (Athens)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-020-01082-w","article-title":"Prevention, diagnosis, and management of hypertensive disorders of pregnancy: a comparison of international guidelines","volume":"22","author":"Sinkey RG","year":"2020","unstructured":"Sinkey RG, Battarbee AN, Bello NA, Ives CW, Oparil S, Tita AT. Prevention, diagnosis, and management of hypertensive disorders of pregnancy: a comparison of international guidelines. Curr Hypertens Rep. 2020, 22:66. 10.1007\/s11906-020-01082-w","journal-title":"Curr Hypertens Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn189","article-title":"Recreational physical activity and the risk of preeclampsia: a prospective cohort of Norwegian women","volume":"168","author":"Magnus P","year":"2008","unstructured":"Magnus P, Trogstad L, Owe KM, Olsen SF, Nystad W. Recreational physical activity and the risk of preeclampsia: a prospective cohort of Norwegian women. Am J Epidemiol. 2008, 168:952-7. 10.1093\/aje\/kwn189","journal-title":"Am J Epidemiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20192434","article-title":"Study of labetalol vs. methyldopa in treatment of pregnancy induced hypertension","volume":"8","author":"Gurjar BG","year":"2019","unstructured":"Gurjar BG, Malewar SS. Study of labetalol vs. methyldopa in treatment of pregnancy induced hypertension. IJRCOG. 2019, 8:2378-83. 10.18203\/2320-1770.ijrcog20192434","journal-title":"IJRCOG"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113055","article-title":"Vascular dysfunction in preeclampsia","volume":"10","author":"Opichka MA","year":"2021","unstructured":"Opichka MA, Rappelt MW, Gutterman DD, Grobe JL, McIntosh JJ. Vascular dysfunction in preeclampsia. Cells. 2021, 10:10.3390\/cells10113055","journal-title":"Cells"},{"key":"ref14","article-title":"Pregnancy-induced hypertension--a particular pathogenic model. similarities with other forms of arterial hypertension","volume":"50","author":"Gluhovschi G","year":"2012","unstructured":"Gluhovschi G, Gluhovschi A, Petrica L, Anastasiu D, Gluhovschi C, Velciov S. Pregnancy-induced hypertension--a particular pathogenic model. similarities with other forms of arterial hypertension. Rom J Intern Med. 2012, 50:71-81.","journal-title":"Rom J Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.31729\/jnma.6392","article-title":"Pregnancy induced hypertension among pregnant women delivering in a tertiary care hospital: a descriptive cross-sectional study","volume":"59","author":"Thapa T","year":"2021","unstructured":"Thapa T, Sharma S, Sigdel D, Silwal K, Joshi A. Pregnancy induced hypertension among pregnant women delivering in a tertiary care hospital: a descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2021, 59:1209-14. 10.31729\/jnma.6392","journal-title":"JNMA J Nepal Med Assoc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1249\/01.mss.0000175862.41620.41","article-title":"Perceived exertion during prepregnancy physical activity and preeclampsia risk","volume":"37","author":"Rudra CB","year":"2005","unstructured":"Rudra CB, Williams MA, Lee IM, Miller RS, Sorensen TK. Perceived exertion during prepregnancy physical activity and preeclampsia risk. Med Sci Sports Exerc. 2005, 37:1836-41. 10.1249\/01.mss.0000175862.41620.41","journal-title":"Med Sci Sports Exerc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2023.04.010","article-title":"Participation in the centering pregnancy program and pregnancy-induced hypertension","volume":"65","author":"Momodu OA","year":"2023","unstructured":"Momodu OA, Horner RD, Liu J, Crouch EL, Chen BK. Participation in the centering pregnancy program and pregnancy-induced hypertension. Am J Prev Med. 2023, 65:476-84. 10.1016\/j.amepre.2023.04.010","journal-title":"Am J Prev Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.01.029","article-title":"Micronutrient supplementation during pregnancy and the risk of pregnancy-induced hypertension: A randomized clinical trial","volume":"38","author":"Chen S","year":"2019","unstructured":"Chen S, Li N, Mei Z, Ye R, Li Z, Liu J, Serdula MK. Micronutrient supplementation during pregnancy and the risk of pregnancy-induced hypertension: A randomized clinical trial. Clin Nutr. 2019, 38:146-51. 10.1016\/j.clnu.2018.01.029","journal-title":"Clin Nutr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2022.11.009","article-title":"Blood pressure changes in gestational hypertension, preeclampsia, and chronic hypertension from preconception to 42-day postpartum","volume":"31","author":"Palatnik A","year":"2023","unstructured":"Palatnik A, Mukhtarova N, Hetzel SJ, Hoppe KK. Blood pressure changes in gestational hypertension, preeclampsia, and chronic hypertension from preconception to 42-day postpartum. Pregnancy Hypertens. 2023, 31:25-31. 10.1016\/j.preghy.2022.11.009","journal-title":"Pregnancy Hypertens"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.24875\/BMHIM.22000069","article-title":"Hematological disorders in preterm newborns born to mothers with pregnancy-induced hypertension","volume":"79","author":"Arce-L\u00f3pez KL","year":"2022","unstructured":"Arce-L\u00f3pez KL, Iglesias-Leboreiro J, Bern\u00e1rdez-Zapata I, Rend\u00f3n-Mac\u00edas ME, Miranda Madrazo MR. Hematological disorders in preterm newborns born to mothers with pregnancy-induced hypertension. Bol Med Hosp Infant Mex. 2022, 79:363-8. 10.24875\/BMHIM.22000069","journal-title":"Bol Med Hosp Infant Mex"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","author":"Roberts JM","year":"2013","unstructured":"Roberts JM, August PA, Bakris G, et al.. Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013, 122:1122-31. 10.1097\/01.AOG.0000437382.03963.88","journal-title":"Obstet Gynecol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612743","article-title":"Endogenous digitalis-like factors as a key molecule in the pathophysiology of pregnancy-induced hypertension and a potential therapeutic target in preeclampsia","volume":"24","author":"Socha MW","year":"2023","unstructured":"Socha MW, Chmielewski J, Pietrus M, Wart\u0119ga M. Endogenous digitalis-like factors as a key molecule in the pathophysiology of pregnancy-induced hypertension and a potential therapeutic target in preeclampsia. Int J Mol Sci. 2023, 24:10.3390\/ijms241612743","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2018.01.012","article-title":"Hypertensive disorders in pregnancy","volume":"45","author":"Sutton AL","year":"2018","unstructured":"Sutton AL, Harper LM, Tita AT. Hypertensive disorders in pregnancy. Obstet Gynecol Clin North Am. 2018, 45:333-47. 10.1016\/j.ogc.2018.01.012","journal-title":"Obstet Gynecol Clin North Am"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.13-1-57","article-title":"Renal disease and hypertension in pregnancy","volume":"13","author":"Palma-Reis I","year":"2013","unstructured":"Palma-Reis I, Vais A, Nelson-Piercy C, Banerjee A. Renal disease and hypertension in pregnancy. Clin Med (Lond). 2013, 13:57-62. 10.7861\/clinmedicine.13-1-57","journal-title":"Clin Med (Lond)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.120230","article-title":"Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study","volume":"185","author":"Wang IK","year":"2013","unstructured":"Wang IK, Muo CH, Chang YC, et al.. Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study. CMAJ. 2013, 185:207-13. 10.1503\/cmaj.120230","journal-title":"CMAJ"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-071653","article-title":"Hypertensive disorders of pregnancy","volume":"381","author":"Wu P","year":"2023","unstructured":"Wu P, Green M, Myers JE. Hypertensive disorders of pregnancy. BMJ. 2023, 381:e071653. 10.1136\/bmj-2022-071653","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.emc.2023.01.002","article-title":"Hypertensive disorders of pregnancy","volume":"41","author":"Coggins N","year":"2023","unstructured":"Coggins N, Lai S. Hypertensive disorders of pregnancy. Emerg Med Clin North Am. 2023, 41:269-80. 10.1016\/j.emc.2023.01.002","journal-title":"Emerg Med Clin North Am"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4103\/ijpvm.IJPVM_300_17","article-title":"Effect of self-care before and during pregnancy to prevention and control preeclampsia in high-risk women","volume":"10","author":"Rasouli M","year":"2019","unstructured":"Rasouli M, Pourheidari M, Hamzeh Gardesh Z. Effect of self-care before and during pregnancy to prevention and control preeclampsia in high-risk women. Int J Prev Med. 2019, 10:21. 10.4103\/ijpvm.IJPVM_300_17","journal-title":"Int J Prev Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j3024","article-title":"Lifestyle in progression from hypertensive disorders of pregnancy to chronic hypertension in Nurses' Health Study II: observational cohort study","volume":"358","author":"Timpka S","year":"2017","unstructured":"Timpka S, Stuart JJ, Tanz LJ, Rimm EB, Franks PW, Rich-Edwards JW. Lifestyle in progression from hypertensive disorders of pregnancy to chronic hypertension in Nurses' Health Study II: observational cohort study. BMJ. 2017, 358:j3024. 10.1136\/bmj.j3024","journal-title":"BMJ"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown MA","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC, et al.. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018, 72:24-43. 10.1161\/HYPERTENSIONAHA.117.10803","journal-title":"Hypertension"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31282-6","article-title":"Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial","volume":"394","author":"Easterling T","year":"2019","unstructured":"Easterling T, Mundle S, Bracken H, et al.. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. Lancet. 2019, 394:1011-21. 10.1016\/S0140-6736(19)31282-6","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/2050312119843700","article-title":"Hypertension in pregnancy: Pathophysiology and treatment","volume":"7","author":"Braunthal S","year":"2019","unstructured":"Braunthal S, Brateanu A. Hypertension in pregnancy: Pathophysiology and treatment. SAGE Open Med. 2019, 7:2050312119843700. 10.1177\/2050312119843700","journal-title":"SAGE Open Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.02.037","article-title":"Delayed postpartum preeclampsia: an experience of 151 cases","volume":"190","author":"Matthys LA","year":"2004","unstructured":"Matthys LA, Coppage KH, Lambers DS, Barton JR, Sibai BM. Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol. 2004, 190:1464-6. 10.1016\/j.ajog.2004.02.037","journal-title":"Am J Obstet Gynecol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2008.02.056","article-title":"Postpartum preeclampsia: emergency department presentation and management","volume":"40","author":"Yancey LM","year":"2011","unstructured":"Yancey LM, Withers E, Bakes K, Abbott J. Postpartum preeclampsia: emergency department presentation and management. J Emerg Med. 2011, 40:380-4. 10.1016\/j.jemermed.2008.02.056","journal-title":"J Emerg Med"},{"key":"ref35","unstructured":"PIH. Major milestones in PIH history. (2024). Accessed: July 1, 2024: https:\/\/www.pih.org\/article\/major-milestones-pih-history."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4314\/ejhs.v29i1.4","article-title":"Pregnancy induced hypertension and associated factors among women attending delivery service at mizan-tepi university teaching hospital, Tepi General Hospital and Gebretsadik Shawo Hospital, Southwest, Ethiopia","volume":"29","author":"Gudeta TA","year":"2019","unstructured":"Gudeta TA, Regassa TM. Pregnancy induced hypertension and associated factors among women attending delivery service at mizan-tepi university teaching hospital, Tepi General Hospital and Gebretsadik Shawo Hospital, Southwest, Ethiopia. Ethiop J Health Sci. 2019, 29:831-40. 10.4314\/ejhs.v29i1.4","journal-title":"Ethiop J Health Sci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-015-0110-5","article-title":"Prevalence of pregnancy induced hypertension and pregnancy outcomes among women seeking maternity services in Harare, Zimbabwe","volume":"15","author":"Muti M","year":"2015","unstructured":"Muti M, Tshimanga M, Notion GT, Bangure D, Chonzi P. Prevalence of pregnancy induced hypertension and pregnancy outcomes among women seeking maternity services in Harare, Zimbabwe. BMC Cardiovasc Disord. 2015, 15:111. 10.1186\/s12872-015-0110-5","journal-title":"BMC Cardiovasc Disord"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011739","article-title":"Maternal pregnancy-induced hypertension increases subsequent neonatal necrotizing enterocolitis risk: A nationwide population-based retrospective cohort study in Taiwan","volume":"97","author":"Yang CC","year":"2018","unstructured":"Yang CC, Tang PL, Liu PY, et al.. Maternal pregnancy-induced hypertension increases subsequent neonatal necrotizing enterocolitis risk: A nationwide population-based retrospective cohort study in Taiwan. Medicine (Baltimore). 2018, 97:e11739. 10.1097\/MD.0000000000011739","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/268803-pregnancy-induced-hypertension-pathophysiology-and-contemporary-management-strategies-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T12:42:11Z","timestamp":1720269731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/268803-pregnancy-induced-hypertension-pathophysiology-and-contemporary-management-strategies-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,6]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.63961","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,6]]}}}